Ultime notizie per ONE Gas (NYSE:OGS) Azioni

ONE Gas

ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. The company controls considerable market shares in Oklahoma and Kansas.

ONE Gas Inc

ORGANIC SALES&MRKTNG INC by Organic Sales and Marketing, Inc.

Spinnaker ETF Series Obra High Grade Structured Products ETF

Overseas Shipholding Group Inc Warrants - Class A (05/08/2039)

During the last three months, 5 analysts shared their evaluations of The Hanover Insurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THG#NYSE">THG</a>), revealing diverse outlooks from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $182.6, a high estimate of $205.00, and a low estimate of $171.00. Surpassing the previous average price target of $178.20, the current average has increased by 2.47%.
<img src="https://www.benzinga.com/files/images/story/2025/1746648068_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of The Hanover Insurance Gr's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$173.00</td>
<td>$171.00</td>
</tr>
<tr>
<td>Greg Miller</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$185.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$171.00</td>
<td>$179.00</td>
</tr>
<tr>
<td>Paul Newsome</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$205.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$179.00</td>
<td>$176.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to The Hanover Insurance Gr. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of The Hanover Insurance Gr compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of The Hanover Insurance Gr's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of The Hanover Insurance Gr's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/THG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on The Hanover Insurance Gr analyst ratings.</a>
<h2>Get to Know The Hanover Insurance Gr Better</h2>
The Hanover Insurance Group Inc is a holding company whose primary business is offering property and casualty insurance products and services. The company markets itself through independent agents and brokers in the United States while conducting business internationally through a wholly owned subsidiary, Chaucer Holdings Limited, domiciled in the United Kingdom. The company conducts business operations through four operating segments: Core Commercial, Specialty, Personal Lines, and Other. The company operates an investment portfolio that is exposed to fixed-income securities.
<h3>The Hanover Insurance Gr: A Financial Overview</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: The Hanover Insurance Gr's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 3.49%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: The Hanover Insurance Gr's net margin is impressive, surpassing industry averages. With a net margin of 8.03%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The Hanover Insurance Gr's ROE stands out, surpassing industry averages. With an impressive ROE of 4.36%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The Hanover Insurance Gr's ROA stands out, surpassing industry averages. With an impressive ROA of 0.83%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.26.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

A Glimpse Into The Expert Outlook On The Hanover Insurance Gr Through 5 Analysts

High-rolling investors have positioned themselves bearish on Tempus AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in TEM often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 11 options trades for Tempus AI. This is not a typical pattern.
The sentiment among these major traders is split, with 27% bullish and 45% bearish. Among all the options we identified, there was one put, amounting to $32,956, and 10 calls, totaling $363,594.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $20.0 and $65.0 for Tempus AI, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Tempus AI's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Tempus AI's whale activity within a strike price range from $20.0 to $65.0 in the last 30 days. 
<h3>Tempus AI Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746648067_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$5.0</td>
<td>$4.8</td>
<td>$4.8</td>
<td>$60.00</td>
<td>$48.0K</td>
<td>9.2K</td>
<td align="right">103</td>
</tr>
<tr>
<td>TEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/30/25</td>
<td>$4.2</td>
<td>$4.0</td>
<td>$4.2</td>
<td>$55.00</td>
<td>$47.8K</td>
<td>173</td>
<td align="right">141</td>
</tr>
<tr>
<td>TEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$5.0</td>
<td>$4.4</td>
<td>$4.6</td>
<td>$60.00</td>
<td>$45.9K</td>
<td>9.2K</td>
<td align="right">203</td>
</tr>
<tr>
<td>TEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$2.05</td>
<td>$1.8</td>
<td>$1.8</td>
<td>$65.00</td>
<td>$36.0K</td>
<td>1.8K</td>
<td align="right">351</td>
</tr>
<tr>
<td>TEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$7.1</td>
<td>$6.9</td>
<td>$7.09</td>
<td>$55.00</td>
<td>$34.0K</td>
<td>1.4K</td>
<td align="right">289</td>
</tr>
</tbody>
</table>

<h3>About Tempus AI</h3>
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Following our analysis of the options activities associated with Tempus AI, we pivot to a closer look at the company's own performance.
<h3>Tempus AI's Current Market Status</h3>
<ul>
<li>With a trading volume of 25,683,651, the price of TEM is up by 10.96%, reaching $57.91.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 90 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Tempus AI</h3>
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $67.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from BTIG downgraded its rating to Buy, setting a price target of $60. 
&#x2A; An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $70. 
&#x2A; An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $70. 
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $70. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Tempus AI, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

Tempus AI's Options: A Look at What the Big Money is Thinking

Whales with a lot of money to spend have taken a noticeably bullish stance on Nike.
Looking at options history for Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) we detected 15 trades.
If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish expectations and 46% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $745,330 and 7, calls, for a total amount of $376,441.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $55.0 to $70.0 for Nike during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Nike stands at 6182.73, with a total volume reaching 7,283.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Nike, situated within the strike price corridor from $55.0 to $70.0, throughout the last 30 days.
<h3>Nike Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746648061_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$5.95</td>
<td>$5.85</td>
<td>$5.85</td>
<td>$57.50</td>
<td>$351.0K</td>
<td>1.5K</td>
<td align="right">600</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$4.15</td>
<td>$4.05</td>
<td>$4.05</td>
<td>$60.00</td>
<td>$101.2K</td>
<td>6.3K</td>
<td align="right">539</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$2.97</td>
<td>$2.92</td>
<td>$2.97</td>
<td>$55.00</td>
<td>$87.0K</td>
<td>2.3K</td>
<td align="right">168</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$8.65</td>
<td>$8.55</td>
<td>$8.65</td>
<td>$65.00</td>
<td>$77.8K</td>
<td>4.5K</td>
<td align="right">360</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$8.65</td>
<td>$8.55</td>
<td>$8.65</td>
<td>$65.00</td>
<td>$77.8K</td>
<td>4.5K</td>
<td align="right">270</td>
</tr>
</tbody>
</table>

<h3>About Nike</h3>
Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.
Having examined the options trading patterns of Nike, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Nike</h3>
<ul>
<li>Trading volume stands at 8,708,833, with NKE's price up by 2.68%, positioned at $58.57.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 50 days.</li>
</ul>
<h3>What Analysts Are Saying About Nike</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $63.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Williams Trading keeps a Buy rating on Nike with a target price of $73. 
&#x2A; An analyst from Citigroup has decided to maintain their Neutral rating on Nike, which currently sits at a price target of $57. 
&#x2A; An analyst from Wells Fargo downgraded its action to Equal-Weight with a price target of $55. 
&#x2A; An analyst from Piper Sandler persists with their Overweight rating on Nike, maintaining a target price of $70. 
&#x2A; An analyst from Stifel has decided to maintain their Hold rating on Nike, which currently sits at a price target of $64. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Nike with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Spotlight on Nike: Analyzing the Surge in Options Activity

In the preceding three months, 15 analysts have released ratings for Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>), presenting a wide array of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">13</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $73.2, a high estimate of $92.00, and a low estimate of $64.00. This current average reflects an increase of 5.32% from the previous average price target of $69.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1746648056_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Rhythm Pharmaceuticals among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joseph Stringer</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$72.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>Tazeen Ahmad</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$68.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Raises</td>
<td>Buy</td>
<td>$80.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Whitney Ijem</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$92.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Joseph Stringer</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$66.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>Derek Archila</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$91.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$70.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Joseph Stringer</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$66.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Jeffrey Hung</td>
<td>Morgan Stanley</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$72.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Paul Matteis</td>
<td>Stifel</td>
<td>Announces</td>
<td>Buy</td>
<td>$78.00</td>
<td>-</td>
</tr>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Raises</td>
<td>Buy</td>
<td>$70.00</td>
<td>$69.00</td>
</tr>
<tr>
<td>Whitney Ijem</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$81.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Joseph Stringer</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$64.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Joseph Stringer</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$64.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Joseph Stringer</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$64.00</td>
<td>$64.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Rhythm Pharmaceuticals. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Rhythm Pharmaceuticals compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Rhythm Pharmaceuticals's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Rhythm Pharmaceuticals's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/RYTM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Rhythm Pharmaceuticals analyst ratings.</a>
<h2>Discovering Rhythm Pharmaceuticals: A Closer Look</h2>
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
<h3>A Deep Dive into Rhythm Pharmaceuticals's Financials</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3M period, Rhythm Pharmaceuticals showcased positive performance, achieving a revenue growth rate of 72.61% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Rhythm Pharmaceuticals's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -112.99% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Rhythm Pharmaceuticals's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -286.92%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -12.51%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Rhythm Pharmaceuticals's debt-to-equity ratio is below the industry average at 0.18, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RYTM

Rhythm Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (15 Ratings)

Financial giants have made a conspicuous bullish move on Chevron. Our analysis of options history for Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) revealed 16 unusual trades.
Delving into the details, we found 50% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $379,167, and 10 were calls, valued at $1,720,172.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $110.0 to $150.0 for Chevron during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Chevron's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Chevron's significant trades, within a strike price range of $110.0 to $150.0, over the past month.
<h3>Chevron Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746648055_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/30/25</td>
<td>$1.4</td>
<td>$1.26</td>
<td>$1.3</td>
<td>$140.00</td>
<td>$650.0K</td>
<td>225</td>
<td>5.0K</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$2.56</td>
<td>$2.45</td>
<td>$2.46</td>
<td>$140.00</td>
<td>$492.0K</td>
<td>3.3K</td>
<td>2.2K</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.71</td>
<td>$2.65</td>
<td>$2.71</td>
<td>$140.00</td>
<td>$187.6K</td>
<td>3.3K</td>
<td>4.2K</td>
</tr>
<tr>
<td>CVX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/23/25</td>
<td>$2.66</td>
<td>$2.56</td>
<td>$2.56</td>
<td>$132.00</td>
<td>$161.2K</td>
<td>36</td>
<td>630</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.71</td>
<td>$2.66</td>
<td>$2.71</td>
<td>$140.00</td>
<td>$158.8K</td>
<td>3.3K</td>
<td>4.2K</td>
</tr>
</tbody>
</table>

<h3>About Chevron</h3>
Chevron is an integrated energy company with exploration, production, and refining operations worldwide. It is the second-largest oil company in the United States with production of 3.0 million of barrels of oil equivalent a day, including 7.7 million cubic feet a day of natural gas and 1.7 million of barrels of liquids a day. Production activities take place in North America, South America, Europe, Africa, Asia, and Australia. Its refineries are in the US and Asia for total refining capacity of 1.8 million barrels of oil a day. Proven reserves at year-end 2024 stood at 9.8 billion barrels of oil equivalent, including 5.1 billion barrels of liquids and 28.4 trillion cubic feet of natural gas.
Following our analysis of the options activities associated with Chevron, we pivot to a closer look at the company's own performance.
<h3>Current Position of Chevron</h3>
<ul>
<li>Trading volume stands at 6,551,714, with CVX's price up by 0.02%, positioned at $135.63.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 86 days.</li>
</ul>
<h3>Professional Analyst Ratings for Chevron</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $151.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Barclays downgraded its rating to Equal-Weight, setting a price target of $152. 
&#x2A; An analyst from Redburn Atlantic has revised its rating downward to Sell, adjusting the price target to $124. 
&#x2A; Reflecting concerns, an analyst from Scotiabank lowers its rating to Sector Perform with a new price target of $143. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on Chevron, maintaining a target price of $173. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Chevron, targeting a price of $164. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Chevron with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Spotlight on Chevron: Analyzing the Surge in Options Activity

14 analysts have expressed a variety of opinions on Mosaic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOS#NYSE">MOS</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $29.79, with a high estimate of $34.00 and a low estimate of $26.00. This upward trend is apparent, with the current average reflecting a 3.55% increase from the previous average price target of $28.77.
<img src="https://www.benzinga.com/files/images/story/2025/1746648046_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A comprehensive examination of how financial experts perceive Mosaic is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$31.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$28.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Andrew Wong</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$30.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Kristen Owen</td>
<td>Oppenheimer</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$33.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Richard Garchitorena</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$28.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Ben Isaacson</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$34.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$33.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Duffy Fischer</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$31.00</td>
<td>-</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$27.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Andrew Wong</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$28.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Richard Garchitorena</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$26.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Christopher Parkinson</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$28.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Ben Isaacson</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Outperform</td>
<td>$31.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Jeffrey Zekaukas</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$29.00</td>
<td>$26.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Mosaic. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Mosaic compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Mosaic's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Mosaic's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MOS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Mosaic analyst ratings.</a>
<h2>All You Need to Know About Mosaic</h2>
Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in Florida, Brazil, and Peru and potash mines in Saskatchewan, New Mexico, and Brazil. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosaic Fertilizantes business.
<h3>Mosaic's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Decline in Revenue: Over the 3M period, Mosaic faced challenges, resulting in a decline of approximately -10.59% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Mosaic's net margin excels beyond industry benchmarks, reaching 6.0%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 1.45%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Mosaic's ROA stands out, surpassing industry averages. With an impressive ROA of 0.73%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Mosaic's debt-to-equity ratio is below the industry average at 0.39, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

14 Analysts Have This To Say About Mosaic

6 analysts have expressed a variety of opinions on Atkore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATKR#NYSE">ATKR</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Atkore, revealing an average target of $69.33, a high estimate of $80.00, and a low estimate of $65.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 11.87%. 
<img src="https://www.benzinga.com/files/images/story/2025/1746648035_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Atkore among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$70.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Jeffrey Hammond</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$80.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$65.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$66.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Jeffrey Hammond</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$70.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Chris Dankert</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Hold</td>
<td>$65.00</td>
<td>$115.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Atkore. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Atkore compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Atkore's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Atkore's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ATKR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Atkore analyst ratings.</a>
<h2>About Atkore</h2>
Atkore Inc is a diversified industrials company and a manufacturer of electrical, mechanical, and safety infrastructure solutions. Atkore has two business segments; Electrical and Safety and Infrastructure. Net sales are highest in the electrical business line. The key product categories in the electrical segment are PVC conduit, steel conduit, and PVC-coated conduit, which are staples for electrical distributors. The key product categories in the safety and infrastructure segment include in-line galvanized mechanical tubes, metal framing and related fittings, and security bollards. Also, the company provides ancillary services to customers in the form of slitting and cutting structural steel sheets. Geographically, the company derives its key revenue from the United States.
<h3>Key Indicators: Atkore's Financial Health</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Atkore's financials over 3M reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately -17.14% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Atkore's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 6.92%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Atkore's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.0%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Atkore's ROA stands out, surpassing industry averages. With an impressive ROA of 1.53%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.63.
<h2>How Are Analyst Ratings Determined?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATKR

Breaking Down Atkore: 6 Analysts Share Their Views

Xometry's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XMTR#NYSE">XMTR</a>) short percent of float has risen 6.16% since its last report. The company recently reported that it has 4.28 million shares sold short, which is 18.6% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.15 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Xometry Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746648029_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Xometry has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Xometry's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Xometry's peer group average for short interest as a percentage of float is 5.08%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

XMTR

How Is The Market Feeling About Xometry?

4 analysts have expressed a variety of opinions on Cirrus Logic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRUS#NASDAQ">CRUS</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $101.75, a high estimate of $125.00, and a low estimate of $80.00. This current average represents a 11.52% decrease from the previous average price target of $115.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1746648027_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The analysis of recent analyst actions sheds light on the perception of Cirrus Logic by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$90.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$80.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Tore Svanberg</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$112.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>David Williams</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$125.00</td>
<td>$125.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Cirrus Logic. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Cirrus Logic compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Cirrus Logic's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Cirrus Logic's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CRUS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Cirrus Logic analyst ratings.</a>
<h2>All You Need to Know About Cirrus Logic</h2>
Cirrus Logic Inc is a provider of integrated circuits for audio and voice signal processing applications. The firm's products are organized into two streams: portable audio products, and HPMS Products. These products include aAmplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, Europe, South Korea, and countries across the world.
<h3>Financial Milestones: Cirrus Logic's Journey</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Challenges: Cirrus Logic's revenue growth over 3M faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -10.22%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Cirrus Logic's net margin is impressive, surpassing industry averages. With a net margin of 20.87%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Cirrus Logic's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.96% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Cirrus Logic's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 4.92%, the company showcases efficient use of assets and strong financial health.
Debt Management: Cirrus Logic's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.07.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CRUS

Breaking Down Cirrus Logic: 4 Analysts Share Their Views

Edwards Lifesciences's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) short percent of float has fallen 16.76% since its last report. The company recently reported that it has 7.93 million shares sold short, which is 1.54% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.5 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Edwards Lifesciences Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746648024_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Edwards Lifesciences has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Edwards Lifesciences's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Edwards Lifesciences's peer group average for short interest as a percentage of float is 4.27%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What's Driving the Market Sentiment Around Edwards Lifesciences?

In the current market session, ON Semiconductor Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) price is at $38.91, after a 1.04% spike. However, over the past month, the stock fell by 0.74%, and in the past year, by 45.40%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1746648019_0.png" alt="Past Year Chart" />

<h3>Evaluating ON Semiconductor P/E in Comparison to Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
ON Semiconductor has a lower P/E than the aggregate P/E of 129.35 of the Semiconductors &amp; Semiconductor Equipment industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1746648019_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

News

Intraday Update

P/E Ratio Insights for ON Semiconductor

12 analysts have expressed a variety of opinions on Waters (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAT#NYSE">WAT</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $400.08, a high estimate of $460.00, and a low estimate of $350.00. Observing a 0.18% increase, the current average has risen from the previous average price target of $399.36. 
<img src="https://www.benzinga.com/files/images/story/2025/1746648019_0_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Waters. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Catherine Ramsey</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$374.00</td>
<td>$355.00</td>
</tr>
<tr>
<td>Elizabeth Garcia</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$360.00</td>
<td>$415.00</td>
</tr>
<tr>
<td>Catherine Ramsey</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$355.00</td>
<td>$407.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$350.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Paul Knight</td>
<td>Keybanc</td>
<td>Announces</td>
<td>Overweight</td>
<td>$460.00</td>
<td>-</td>
</tr>
<tr>
<td>Catherine Ramsey</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$407.00</td>
<td>$396.00</td>
</tr>
<tr>
<td>Rachel Vatnsdal</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$390.00</td>
<td>$380.00</td>
</tr>
<tr>
<td>Sung Ji Nam</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$450.00</td>
<td>$430.00</td>
</tr>
<tr>
<td>Brandon Couillard</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$420.00</td>
<td>$415.00</td>
</tr>
<tr>
<td>Elizabeth Garcia</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$410.00</td>
<td>$405.00</td>
</tr>
<tr>
<td>Derik De Bruin</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$410.00</td>
<td>$430.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$415.00</td>
<td>$360.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Waters. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Waters compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Waters's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Waters's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/WAT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Waters analyst ratings.</a>
<h2>Delving into Waters's Background</h2>
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.
<h3>Breaking Down Waters's Financial Performance</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Waters's remarkable performance in 3M is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 6.5%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 26.51%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Waters's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 13.49% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Waters's ROA excels beyond industry benchmarks, reaching 5.11%. This signifies efficient management of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.93, Waters adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Waters's Future

Q2 Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QTWO#NYSE">QTWO</a>) short percent of float has fallen 22.79% since its last report. The company recently reported that it has 3.08 million shares sold short, which is 5.59% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.6 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Q2 Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746648019_0_1.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Q2 Holdings has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Q2 Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Q2 Holdings's peer group average for short interest as a percentage of float is 9.55%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

QTWO

How Do Investors Really Feel About Q2 Holdings?

Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) has outperformed the market over the past 20 years by 1.56% on an annualized basis producing an average annual return of 9.74%. Currently, Advanced Micro Devices has a market capitalization of $163.45 billion. 
Buying $100 In AMD: If an investor had bought $100 of AMD stock 20 years ago, it would be worth $649.61 today based on a price of $100.61 for AMD at the time of writing.
<h3>Advanced Micro Devices's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746648014_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Advanced Micro Devices Stock In The Last 20 Years

Despite last week&#8217;s market rally, which saw US markets recover losses since President Trump&#8217;s <a href="https://www.benzinga.com/25/04/44756759/new-research-shows-donald-trumps-25-tariffs-could-cost-auto-companies-108billion-report">tariff announcement </a>in early April, American stocks are still underperforming their European counterparts.
The S&amp;P 500 has rallied 12.5% since Trump's reciprocal tariffs <a href="https://www.benzinga.com/25/04/44729384/trump-pauses-tariffs-after-yields-surge-bond-vigilantes-hit-another-homerun-experts-point-to-bond-market-panic-for-reversal">were paused</a>, but the Vanguard Europe ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VGK#NYSE">VGK</a>) is up over 18% in the same timeframe. Despite the ‘Sell America' trade losing some steam, investors still seem to prefer European equities to US equities.
Of course, this surge in European stocks has left most big-name European investments at high valuations. But that doesn&#8217;t mean there are no more good stocks to buy across the Atlantic.
Today, we&#8217;re looking at five European stocks that haven&#8217;t rallied as much as their peers but are still undervalued and have room to run.
Each one ranks high on Benzinga Edge&#8217;s Value rankings, too.
These firms all have a Price-to-Earnings (P/E) ratio under 15, a minimum Benzinga Edge Value score of 85, and sales growth of at least 10% over the last five years. Note that many of these companies trade in the US using securities like American Depository Receipts (ADRs), which function as proxies to international equities but have some differences investors should familiarize themselves with before buying.
<h2 class="wp-block-heading">Equinor ASA</h2>
Benzinga Edge Value Score: 93.23
Equinor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQNR#NYSE">EQNR</a>) is a fully integrated oil and gas company based in Norway. It has a $63.6 billion market cap and a P/E ratio of 7.31. The Norwegian government owns a 67% stake in the firm, but its shares trade on the New York Stock Exchange and European exchanges. Equinor mines for oil on the Norwegian Continental Shelf and also operates solar, wind, and natural gas refineries.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXe9uPC-lJJzFwPSnbTtP5iOa07AApLaHwDVkx3cgQuDwKxkHYYa2lO-9RTR3f16_dikQs_Z3g7lEHrZQy37gWEx79XB6beJnFDwFBMHuGufDDUdQTUnPT_2t2tJ8TyStw0zNFdTng?key=K8dCG8bnYTHY9lvM_fV4Pg" alt="" /></figure>
Equinor&#8217;s revenue has expanded for the last three quarters, the first time it has seen revenue growth in three consecutive quarters since 2022. Despite the recent slowdown, Equinor has grown sales at a 21% clip over the last five years, and its dividend currently yields over 6%. A recent earnings miss caused the stock to drop, but the decline ended at the same level as a previous drawdown, indicating a potential bottom and possible entry point.
<h2 class="wp-block-heading">Adecoagro SA&nbsp;</h2>
Benzinga Edge Value Score: 91.79
With a ticker like that, you can probably guess the industry—Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) is a small-cap agricultural firm headquartered in Luxembourg with operations primarily in South America. Although its market cap is under $1 billion, it posted $1.45 billion in revenue over the last 12 months and has grown sales by 13% in the previous five years.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXcnBdbVblawYAfq6oDU5lbM73vfH85oa82lcWlDQj5q3E0kpFdS3RICq_NqKfr0LPWMpw4LFPSaeOlOITBfhsBBen5KOQW0f8TCkmyW4VAmalQUR7o_a54X1DufAY_0MnQWYK0zgQ?key=K8dCG8bnYTHY9lvM_fV4Pg" alt="" /></figure>
AGRO shares have a P/E ratio of 9.49 and trade at just 0.60 times sales, but recent downgrades from Morgan Stanley and Bank of America sent the stock plunging under $9 per share. It is trading near its 52-week low, but the Relative Strength Index (RSI) is in oversold territory, indicating this selloff might be petering out.
<h2 class="wp-block-heading">Global Ship Lease Inc.&nbsp;</h2>
Benzinga Edge Value Score: 96.89
Global Ship Lease (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSL#NYSE">GSL</a>) is a Greek-based container shipping line with over 60 ships and a market cap of around $760 million. Most of the company's business comes from MAERSK charters, and its sales have grown by 24% over the last five years. It currently trades with a P/E ratio of just 2.28 with a Price-to-Book value of 0.52.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXfOgyaKxvTPC7jixULOPzcVWRVCZC1_kwpZ-pTnfsWfxzIDQ13pdnSZ7oqHHVvR9xR-A7-LPUPNfNNYBTvMRWXt-1VEhuKJNSNFuA-cUOlLkoV4hR-BjNqSISDSSX_3ZUAeULmr_Q?key=K8dCG8bnYTHY9lvM_fV4Pg" alt="" /></figure>
Investing in a shipping company seemed risky once the reciprocal tariff chart was released, and GSL shares plummeted in the days following Trump's Rose Garden announcement. But the stock has rebounded in the weeks following the pause, including a rally that saw eight green candles in nine days. GSL has boosted revenue in six of the last seven quarters as well. Its profit margins are approaching 50%. Jeffries is the only research firm with a rating on the stock, but it&#8217;s a Buy with a price target of $29, indicating an upside of over 35%.
<h2 class="wp-block-heading">Tenaris SA&nbsp;</h2>
Benzinga Edge Value Score: 87.64
Tenaris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TS#NYSE">TS</a>) resides in the energy sector and produces goods used in oil and gas well construction. The company is based in Luxembourg but has operations in the United States, Argentina, Mexico, and Italy. Tenaris builds some of the most resilient tubular goods used in deep-water and horizontal shale wells.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXepep04kxFz5LigOCKkOFTi_Jcao2DZdJkX_HHkYojkCFq8T8MpSe8B2L6nLoHqsJPJr_Zo7zNlybBiY5ztH0IaQWhsyfrz0j42D9UlCkiuz0cMuuXT4RQPoO0i1e-Cg4k-x6jriA?key=K8dCG8bnYTHY9lvM_fV4Pg" alt="" /></figure>
Tenaris is a large-cap firm in the oil and gas space with an $18 billion market cap and $12 billion in annual sales. The company has grown sales by 17.7% over the last five years, but revenue has declined recently. Profit margins have dipped from 26% in December 2023 to 15% in the most recent report in March. The stock fell below the 50-day and 200-day SMAs following the Rose Garden press conference, but the steep decline triggered an oversold reading on the RSI, and shares currently trade at just 9.5 times forward earnings. 
<h2 class="wp-block-heading">Stellantis NV&nbsp;</h2>
Benzinga Edge Value Score: 97.56
A car manufacturer like Stellantis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) might seem like a bold investment choice in a trade war. The company makes popular American brands like Dodge, Jeep, and Ram. However, only 26% of Stellantis's 2024 sales occurred in North America, and the company does nearly 50% of its business in Europe, providing some level of tariff protection. Stellantis made more than $169 billion in sales over the last 12 months with income of $5.92 billion.
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXcIzUAo3AZPVu8UKpGTgkdqpIuMjcVaF-M0OOtPDRxN3cet_4mwFsaLpd-gsOEsoQaF-T5fNXFAFCIhfmKGc89IlU-kM5-nZ3QLXtdyk7PAylOfuFCCTpfxAVmP85hQPqQgH3rYQg?key=K8dCG8bnYTHY9lvM_fV4Pg" alt="" /></figure>
Car manufacturers like Stellantis have been some of the hardest hit stocks during the tariff tumult; its shares are down more than 28% year-to-date. However, it might be an opportune time to take a position in the stock as Stellantis is a large-cap company with a significant global presence. The company grew revenue by 33.6% over the last five years and trades at its cheapest valuation in years at just 4.8 times earnings and 0.16 times sales. The stock also pays a 6% dividend yield with a 36% dividend payout ratio, offering income as well as stock price appreciation. And with the RSI triggering an oversold signal, a momentum reversal could be coming soon.
<h2 class="wp-block-heading">The Market's Out of Control – You Don't Have to Be</h2>
Seize back control with Benzinga Edge – your investment command center. With real-time portfolio alerts, actionable stock ideas, and pro-grade tools…you get the complete investor's arsenal — ready to help you profit in any market. Take Back Control Now – Get Your Edge <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-4/?el=ResearchDaily&amp;he=%7B%7Bemail%7D%7D&amp;adt_ei=%7B%7Bemail%7D%7D&amp;utm_adType=SponsorAd&amp;utm_ad=RD0508&amp;utm_campaign=commandcenter">HERE</a>
Editorial content from our Expert contributors is intended to be information for the general public and not individualized investment advice. Editors/contributors are presenting their individual opinions and strategies, which are neither expressly nor impliedly approved or endorsed by Benzinga.
Photo: Shutterstock

Opinion

AGRO

EQNR

STLA

5 European Stocks Rated High On Our Value Rankings

A surprising trend is emerging: more Americans are claiming <a href="https://www.benzinga.com/personal-finance/25/04/45098780/social-security-panic-is-premature-experts-say-delaying-claims-still-yields-bigger-checks-despite-2033-trust-fund-clock">Social Security benefits</a> — and doing so earlier than expected. In March alone, more than 580,000 people filed initial claims for Social Security. That's an increase of about 80,000 from March 2024, according to data presented at a recent Social Security Administration <a href="https://youtu.be/d4Z2teGboLY?si=vkMvLAvyOXY8gUkX&amp;t=1368">meeting</a>.
So, what's fueling the rush? Experts and officials point to a mix of factors — including fear, financial pressure, and policy changes — that are leading many to take the leap sooner than planned.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">Fear Over Social Security's Future</h2>
At the heart of the surge is a growing anxiety about the stability of the Social Security program itself. Leland Dudek, acting commissioner of the SSA, said during the March 28meeting that many people are rushing to claim benefits because they're afraid they might lose out altogether.&nbsp;
"Fearmongering has driven people to claim benefits earlier," he said, and SSA staff confirmed his observation.
This fear isn't unfounded. The <a href="https://www.ssa.gov/OACT/TRSUM/">2024 Social Security Trustees Report</a> predicts that the trust fund could be depleted by 2035. If that happens without reform, beneficiaries might face a 17% cut in benefits. That kind of uncertainty is causing many to take what they can now, just in case.
The political climate is also contributing to the unease. Recent cost-cutting measures by the Department of Government Efficiency, led by Elon Musk under the Trump administration, have caused <a href="https://www.benzinga.com/government/25/04/44941777/social-security-payments-could-face-interruptions-in-may-warns-former-commissioner-martin-omalley-never-hoped-i-was-wrong-so-much-in-my-life">staffing cuts</a>, website outages, and agency disruption. While officials stress that no field offices have permanently closed, leaked plans and long wait times are adding to public anxiety.
Trending: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?
<h2 class="wp-block-heading">Demographic Shifts and Policy Changes</h2>
Fear isn't the only factor driving the surge. A wave of baby boomers is now reaching retirement age, increasing the number of eligible applicants. On top of that, the <a href="https://www.benzinga.com/personal-finance/25/01/42935393/millions-of-public-employees-to-see-boosted-social-security-payments-after-biden-signed-social-security-fairness-act-into-law">Social Security Fairness Act</a>, passed on Jan. 5, has prompted a fresh group of public sector workers to file new claims.
These structural shifts in the retirement landscape are naturally pushing numbers higher. But the size and timing of the March spike still stand out. The data shared in the SSA meeting shows that benefit claims typically dip in early months of the year — making this 16% jump all the more unusual.
<h2 class="wp-block-heading">Job Losses and Rising Costs Add Pressure</h2>
The economy is also playing a role. Some near-retirees are being pushed into retirement involuntarily due to job losses. The <a href="https://www.bls.gov/news.release/pdf/empsit.pdf">April jobs report</a> showed that long-term unemployment of 27 weeks or more hit its highest rate in three years.
At the same time, inflation and market volatility have many older Americans feeling financially vulnerable. Social Security, which adjusts annually for cost-of-living, offers a predictable income stream — something increasingly attractive in uncertain times.
See Also: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
<h2 class="wp-block-heading">Is Early Claiming the Right Move?</h2>
Financial experts caution against making decisions based purely on fear. Claiming benefits early — as soon as age 62 — can result in a permanently reduced monthly check. Those who wait until full retirement age at the typical 67 or age 70 receive significantly higher payments.
Still, nearly 30% of people claim at age 62, and another 32% before reaching full retirement age, according to <a href="https://finance.yahoo.com/news/how-financial-advisers-are-calming-clients-fears-about-the-future-of-social-security-140405188.html">Yahoo Finance</a>.
"Social Security claiming is amongst the most important financial decisions that older households make and can determine not only the income that individuals receive from Social Security but can also potentially influence financial well-being in the years following initial claiming," researchers from Georgetown University's Center for Retirement Initiatives <a href="https://cri.georgetown.edu/wp-content/uploads/2025/03/CRI-WP-2025-01.pdf">wrote</a>.&nbsp;
For those concerned, experts suggest reviewing benefit estimates, speaking with a financial planner, and, if needed, contacting your congressional representative for help navigating the system.
<h2 class="wp-block-heading">Bottom Line</h2>
With economic uncertainty and political changes stirring public concern, it&#8217;s no surprise that more Americans are <a href="https://www.benzinga.com/personal-finance/25/04/44657139/suze-orman-says-stop-collecting-social-security-early-because-you-could-be-sabotaging-your-financial-futurehttps://www.benzinga.com/personal-finance/25/04/44657139/suze-orman-says-stop-collecting-social-security-early-because-you-could-be-sabotaging-your-financial-future">claiming Social Security early</a>. While the decision is deeply personal, it's one that should be made with a full understanding of the long-term impact — not just the short-term headlines.
Read Next:
<ul>
<li>Donald Trump just announced a $500 billion AI infrastructure deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">here's how you can invest in the entertainment market's next big disruptor at $2.25 per share</a>.</li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Personal Finance

80,000 More Americans Filed For Social Security In March Compared With Last Year – What's Driving This Surge?

Coinbase Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) could show the company's leadership in the cryptocurrency ecosystem with first-quarter financial results after <a href="https://www.benzinga.com/earnings">market close Wednesday.</a>
Earnings Estimates: Analysts expect Coinbase to report first-quarter revenue of $2.13 billion, up from $1.64 billion in last year's first quarter, according to data <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0507">from Benzinga Pro. </a>
The company beat analyst estimates for revenue in the last reported quarter, while beating estimates in eight of the last 10 quarters overall.
Analysts expect Coinbase to report first-quarter earnings per share of $2.12, up from $1.65 in last year's first quarter. The company has beaten analyst estimates for earnings per share in eight straight quarters and eight of the last 10 quarters overall.
Read Also:<a href="https://www.benzinga.com/25/05/45244364/coinbase-spikes-in-after-hours-trading-after-partnership-with-lol-valorant-developer-riot-games"> Coinbase Stock Trades Higher After-Hours Amid Partnership With League Of Legends, Valorant Developer Riot Games</a>
What Analysts Are Saying: Rosenblatt analyst Chris Brendler recently warned that "crypto winter" could be underway and it <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44869664/coinbase-global-goes-from-boom-to-bust-amid-crypto-winter-analyst-trims-q1-estimates">could hurt momentum</a> for Coinbase stock.
The analyst said sentiment on crypto has reversed with "sharply rising macro concerns."
Brendler reiterated a Buy rating on the stock while lowering the price target from $305 to $290.
The analyst said Coinbase's trading volumes in March were likely lower than expected. Brendler sees a rebound in crypto-related trading activity in the second half of 2025.
"In our view, legislative clarity will accelerate blockchain technology adoption and COIN will be a primary beneficiary," Brendler said.
Goldman Sachs analyst James Yaro<a href="https://www.benzinga.com/government/regulations/25/03/44421767/coinbase-analyst-cautiously-optimistic-on-stock-with-balanced-riskreward-says-regulatory-e"> sees a balanced risk/reward </a>for Coinbase heading into the earnings report. The analyst took over coverage of Coinbase at Goldman Sachs after the stock was previously covered by Will Nance.
Yaro gave Coinbase a Neutral rating and a $195 price target.
With pure-play exposure to the cryptocurrency sector, Yaro sees long-term growth for Coinbase as the crypto ecosystem expands.
&#8220;We are cautiously optimistic on COIN, but see a balance of upside and downside risks,&#8221; Yaro said.
Yaro highlights a positive regulatory environment for crypto that could support Coinbase&#8217;s growth, but also be a negative.
&#8220;Longer-term, regulatory reform could increase the crypto TAM, but also bring in competitors from across financial services. Competition could pressure COIN&#8217;s market share and pricing over time.&#8221;
Here are other recent <a href="https://www.benzinga.com/quote/COIN/analyst-ratings">analyst ratings on Coinbase</a> and their price targets:
<ul>
<li>Citigroup: Maintained Buy rating, lowered price target from $350 to $270</li>
<li>JPMorgan: Maintained Neutral rating, lowered price target from $344 to $276</li>
<li>Benchmark: Initiated with Buy rating, $252 price target</li>
</ul>
Key Items to Watch: Analysts and investors will be looking at many items in Coinbase's earnings report with the price of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) trading strong in January before falling in March.
Transaction revenue was up 172% quarter-over-quarter in the fourth quarter. This could be a key item to show whether Coinbase continues its leadership in the cryptocurrency ecosystem and also if traders were active in the first quarter with Donald Trump inaugurated and high volatility during the quarter.
Subscription and services has been a bright spot for Coinbase in recent quarters, bringing the company high-margin recurring revenue. Subscription and services revenue of $641 million in the fourth quarter was up 15% quarter-over-quarter and came in ahead of company guidance. The company<a href="https://www.benzinga.com/25/02/43713994/coinbase-q4-earnings-highlights-revenue-beat-consumer-trading-volume-940-billion-company-welcomes-dawn-of-a-new-era-for-crypto"> is guiding for </a>first-quarter subscription and services revenue in a range of $685 million to $765 million.
Bitcoin made up 27% of both trading volume and transaction revenue in the fourth quarter. This was down from 37% and 35% respectively, in the third quarter. The new quarterly results will show if Bitcoin regained its dominance or saw lower activity due to other cryptocurrencies.
XRP Token (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) could be another item to watch after making up 14% of transaction revenue in the fourth quarter and seeing strong demand from Coinbase users.
COIN Price Action: Coinbase stock is down 0.7% to $195.47 on Wednesday versus a 52-week trading range of $142.58 to $349.75. Coinbase stock is down 21.4% year-to-date in 2025 and down 8.9% over the last year.
The drop in Coinbase's stock price comes with Bitcoin up 3.1% year-to-date and up 54.5% over the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43591727/coinbase-ceo-brian-armstrong-says-bitcoin-adoption-to-reach-billions-by-2030">Coinbase CEO Brian Armstrong Says Bitcoin Adoption To Reach &#8216;Billions&#8217; By 2030</a></li>
</ul>
Image: Shutterstock

Analyst Color

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Price Target

Previews

Reiteration

$BTC

$XRP

COIN

Coinbase Q1 Earnings Preview: Trump Inauguration, Bitcoin Surge And More Items To Watch

Electronic Arts Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>) released its <a target="_blank" href="https://www.benzinga.com/general/gaming/25/05/45238060/electronic-arts-stock-climbs-after-better-than-expected-q4-report" rel="noreferrer noopener">fourth-quarter results</a> after Tuesday&#8217;s closing bell.&nbsp;
Wall Street analysts rerated the stock after the report.
Wedbush analyst Michael Pachter reiterated Electronic Arts with an Outperform and raised the <a target="_blank" href="https://www.benzinga.com/quote/EA/analyst-ratings" rel="noreferrer noopener">price target from&nbsp;$179&nbsp;to&nbsp;$210</a>.
JP Morgan analyst Cory A Carpenter maintained Electronic Arts with a Neutral and raised the price target from&nbsp;$135&nbsp;to&nbsp;$160.
Also Read: <a href="https://www.benzinga.com/25/03/44524101/take-two-and-roblox-set-for-big-2025-gains-as-gta-vi-mobile-growth-and-ads-drive-momentum-analyst" target="_blank" rel="noreferrer noopener">JP Morgan&#8217;s Top Video Game Stocks Of 2025</a>
Wedbush: Electronic Arts reported net bookings of $1.799 billion compared with Pachter&#8217;s estimate of $1.594 billion, consensus of $1.550 billion, and guidance of $1.444 billion-1.594 billion. Revenues exceeded expectations, driven by a rebound in EA SPORTS FC, the successful launch of Split Fiction, double-digit net bookings growth in The Sims, and continued strength in American Football titles. 
Adjusted EPS was $1.58, compared with Pachter&#8217;s estimate of $1.21, consensus of $1.10, and guidance of $0.76– 1.17. Fiscal 2026 guidance for net bookings of $7.600 billion-8.000 billion and adjusted EPS of $7.60-8.40, compared with Pachter&#8217;s prior estimates of $7.830 billion and $8.38 and previous consensus of $7.900 billion and $6.93. 
First-quarter 2026 guidance is for net bookings of $1.175 billion-1.275 billion and EPS of $(0.05)-0.15, compared with Pachter&#8217;s prior estimates of $1.250 billion and $0.51, and prior consensus of $1.264 billion and $0.23. First-quarter guidance assumes seasonally lower revenue, a five-point drag from Apex Legends, and a two-point drag from the catalog. Excluding Apex Legends, EA expects low single-digit live services growth in the period.
Pachter noted that the launch of Battlefwill likely result in sales of 7 million-15 million units for the year and expects Skate to add 3 million-5 million units more. At the low end, these titles should contribute $500 million of year-over-year growth; at the high end, they should contribute $1 billion. 
Perhaps more importantly, Electronic Arts&#8217; guidance contemplates that retail game prices will remain $70 for Xbox Series and PS5 releases. Electronic Arts noted it is highly likely that the company can raise prices for ALL of its new releases by $10 at retail, allowing it to capture $350 million of bookings growth in fiscal 2026 with only modest performance from its latest titles.
Pachter projected first-quarter revenue of $1.28 billion and EPS of $0.15.
JP Morgan: Three months ago, investors debated if the FC slowdown was temporary or structural, Dragon Age disappointed, and a Battlefield release in fiscal 2026 was uncertain due to GTA VI. A lot has changed in three months. FC proved to be a temporary &#8220;ebb,&#8221; the delay of GTA VI opened a window for Battlefield to launch in fiscal 2026, and Split Fiction nearly doubled expectations, according to Carpenter.
Carpenter listed his takeaways from management calls. The outlook does not include game price increases, but the analyst would not interpret them as off the table. Battlefield unit assumptions are prudent, given that the game has been out of the market for about four years. 
The analyst noted Electronic Arts could achieve the low end of its fiscal 2027 margin framework a year early in a Battlefield &#8220;blue sky&#8221; scenario. The fiscal first-quarter outlook reflects FC trends consistent with recent weeks, which could prove conservative given the significant upcoming events in the quarter.
Battlefield will have live services tied to it, but management has yet to disclose the timing. Carpenter noted the outlook reflects Battlefield live services assumptions that are even more conservative than unit assumptions.
Apex 2.0 release timing will likely be further out so as not to conflict with Battlefield.
Catalog is a bigger headwind than Apex for the fiscal year, but Apex is a bigger headwind in the fiscal first quarter.
Carpenter did not anticipate any material change to the dividend.
He projected first-quarter revenue of $1.6 billion and adjusted EPS of $0.04.
Price Action: EA stock is up 1% at $156.08 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45252365/fiverr-beats-q1-on-strong-buyer-spend-and-ai-push-lifts-2025-revenue-outlook" target="_blank" rel="noreferrer noopener">Fiverr Beats Q1 Estimates On Strong Buyer Spend, AI Push, Lifts 2025 Revenue Outlook</a></li>
</ul>
Photo: Shutterstock

EA's Strong Quarter Turns Heads On Wall Street As Analysts Reassess The Road Ahead

Major cryptocurrencies are trading slightly higher following the Federal Reserve keeping interest rates unchanged and China's liquidity boost to stimulate its economy.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$96,034.89</td>
<td>+1%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$1,792.80</td>
<td>+0.2%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$145.55</td>
<td>+0.4%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.10</td>
<td>-1.6%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1700</td>
<td>+0.6%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001262</td>
<td>+0.3%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume decreasing by 9.4% and daily active addresses growing by 3.2%. Transactions greater than $100,000 are down from 9,843 to 9,668 in a single day. Exchanges netflows are down by 140.2%.</li>
<li>Coinglass data reports 102,179 traders were liquidated in the past 24 hours for $239.75 million.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/25/05/45260729/ethereums-pectra-upgrade-goes-live-reshapes-wallet-logic-and-raises-security-and-bandwidth-concerns">Ethereum&#8217;s Pectra Upgrade Goes Live: Here&#8217;s What You Need To Know</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45257429/michael-saylor-calls-bitcoin-the-corporate-survival-strategy-for-96-of-companies">Michael Saylor Calls Bitcoin The &#8216;Corporate Survival Strategy&#8217; For 96% of Companies</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45248407/rabbitx-founder-eyes-real-world-assets-and-liquidity-tokenization-as-the-future-of-perpetual-trading">RabbitX Founder Eyes Real-World Assets And Liquidity Tokenization As The Future Of Perpetual Trading</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45262012/treasury-sec-scott-bessent-us-should-be-the-premier-destination-for-digital-assets">Treasury Sec Scott Bessent: US Should Be The &#8216;Premier Destination For Digital Assets&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45253032/anthony-scaramucci-gives-donald-trump-b-or-a-on-crypto-but-warns-presidential-meme-coin-defi-project-risk-derailing-policy-progress">Anthony Scaramucci Gives Donald Trump &#8216;B+ Or A-&#8216; On Crypto But Warns Presidential Meme Coin, DeFi Project Risk Derailing Policy Progress</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45248184/bitcoin-is-no-longer-just-digital-gold-native-staking-yield-are-redefining-its-role-says-core-dao">Bitcoin Is No Longer Just Digital Gold — Native Staking, Yield Are Redefining Its Role, Says Core DAO</a></li>
<li><a href="https://www.benzinga.com/25/05/45245329/strike-launches-new-service-allowing-users-to-borrow-up-to-2-million-backed-by-bitcoin">Have Bitcoin? Need Cash? Strike Launches New Product Allowing Users To Borrow Up To $2 Million</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>EOS (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eos/usd">EOS</a>)</td>
<td>&nbsp;$0.7813</td>
<td>+13.8%</td>
</tr>
<tr>
<td>Stacks (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/stx/usd">STX</a>)</td>
<td>&nbsp;$0.8459</td>
<td>+10.2%</td>
</tr>
<tr>
<td>Zcash (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/zec/usd">ZEC</a>)</td>
<td>&nbsp;$39.78</td>
<td>+9%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader McKenna <a href="https://x.com/Crypto_McKenna/status/1920190448364388552">emphasized</a> that Bitcoin's explosive rise from $15,000 post-FTX to $110,000 has occurred despite interest rates holding steady at 4.25%–4.5%, underscoring that the rally is not rate-driven. 
Instead, he credits the move to structural adoption, particularly by institutions, and Bitcoin&#8217;s growing role as a non-sovereign store of value and hedge against capital controls. 
The parabolic trend, he notes, reflects a global shift in perception rather than temporary macro factors.
Inmortal echoed this long-term bullishness, pointing out that after long stretches of vertical accumulation, there's usually a "banger move" and we may still see more upside before a major deviation.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Even in vertical accumulations we get this banger at some point. We may have more upside before we have a deviation, but when it comes, I&#39;ll go big.<a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> <a href="https://t.co/3tGmUp5kMD">pic.twitter.com/3tGmUp5kMD</a>
&mdash; Inmortal (@inmortalcrypto) <a href="https://twitter.com/inmortalcrypto/status/1920192912224366700?ref_src=twsrc%5Etfw">May 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
ShardiB2 kept it simple: "Bitcoin daily looks fine — Above blue line, green dots," signaling a continued uptrend.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> daily looks fine Above blue line, green dots <a href="https://t.co/TtEi2sFvEI">pic.twitter.com/TtEi2sFvEI</a>
&mdash; Don&#39;t follow Shardi B if you hate Money (@ShardiB2) <a href="https://twitter.com/ShardiB2/status/1920192256545374307?ref_src=twsrc%5Etfw">May 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, Crypto Seth <a href="https://x.com/seth_fin/status/1920176983587131838">advised</a> traders to stay focused amid expected short-term volatility following Jerome Powell's speech. "This BTC cycle isn't done, we've still got more to go," he asserted, urging market participants to keep their eyes on the bigger picture.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45259065/bitcoin-hovers-around-97000-but-a-correction-may-be-around-the-corner-traders-warn">Bitcoin Hovers Around $97,000, But A Correction May Be Around The Corner, Traders Warn</a></li>
</ul>
Image: Shutterstock

Comments

ONE Gas

Notizie

Ultime notizie per ONE Gas (NYSE:OGS) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO